SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-97-000026
Filing Date
1997-02-05
Accepted
1997-02-05 00:00:00
Documents
1
Group Members
CITIBANK NACITICORP
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G FOR CELL THERAPEUTICS, INC. SC 13G 12400
  Complete submission text file 0000947871-97-000026.txt   14541
Mailing Address 425 PARK AVE- 2ND F ATTN: LEGAL AFFAIRS OFFICE NEW YORK NY 10043
Business Address 399 PARK AVE NEW YORK NY 10043 2125591000
CITICORP (Filed by) CIK: 0000020405 (see all company filings)

IRS No.: 132614988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6021 National Commercial Banks

Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 97518720
SIC: 2834 Pharmaceutical Preparations